General Information of Drug (ID: DM7WTP4)

Drug Name
VX-880
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Phase 1/2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D08ZSJ

References

1 ClinicalTrials.gov (NCT04786262) A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia. U.S.National Institutes of Health.